The observation that CTLA-4negative anti-CD123 CAR T cells exhibit higher cytotoxicity in the presence of AZA pre-treated AML cells was made when using MOLM-13 and OCI-AML3 cells. The gene discussed is RUNX2; the disease is acute myeloid leukemia.